Dr. Walkiria R. Jimenez-Loo, MD

Dr. Jimenez-Loo practices at Operating Room Allen Hospital - HOPD in New York, New York.

Dr. Jimenez-Loo's NPI, 1992901045, was assigned on June 25, 2007. Dr. Jimenez-Loo graduated from Icahn School Of Medicine At Mount Sinai in 2007. Dr. Jimenez-Loo's New York license number on file is 272873.

Dr. Jimenez-Loo's primary practice is Operating Room Allen Hospital - HOPD, at 5141 Broadway, New York, NY 10034.

Dr. Jimenez-Loo's primary practice is Operating Room Allen Hospital - HOPD in New York, New York. Dr. Jimenez-Loo is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Jimenez-Loo to 2 more group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jimenez-Loo practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Jimenez-Loo's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Jimenez-Loo is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Jimenez-Loo's licenses on file in 3 states: New York, Oregon and Colorado.

Dmand AI lists acute diabetes, acute respiratory failure, cellulitis, chest trauma, circulation problems, dementia, electrolyte disorders and gastrointestinal bleeding among the conditions Dr. Jimenez-Loo treats.

CMS data shows 354 Medicare services from Dr. Jimenez-Loo across 4 procedure codes in 2024, for 169 Medicare patients. Medicare paid $34,755 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Jimenez-Loo in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jimenez-Loo's median patient age at 76, with 55% women.

In 2024, Dr. Jimenez-Loo wrote 89 Medicare Part D claims for 21 patients. 87% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $70 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jimenez-Loo for performance year 2024, reported through an alternative payment model (APM). Dr. Jimenez-Loo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Jimenez-Loo from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $21.

Dr. Jimenez-Loo graduated from Icahn School Of Medicine At Mount Sinai in 2007. Dr. Jimenez-Loo is a member of ACP.

Dr. Jimenez-Loo is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.